Robots Profit as Pfizer (PFE) Shares Drop Over 1.5% in a Calm Market: A Winning Trade
Yesterday, futures tied to the Dow Jones Industrial Average fell by 111 points, or approximately 0.34%. S&P 500 futures declined by 0.28%, while Nasdaq 100 futures dropped by 0.25%. Our robots performed better than the market yesterday, as there was a slight increase in the broad market. However, it is still not sufficient to speak of a strong growing market. The broad market remains weak, and only individual stocks are showing some upward movement.
Our robots have been able to make profits from short positions on certain stocks. One example is Pfizer, which our robots were short on, and it lost over 1.5% yesterday. The market is very volatile, and I recommend exercising caution when making trades at the moment. However, it is likely that the market will determine its direction in the near future.
The Stochastic Oscillator appears to be transitioning from an upward trend to a downward trend. In 34 out of 59 instances where PFE's Stochastic Oscillator exited the overbought zone, the price subsequently declined within the following month. The likelihood of a continued downward trend is estimated at 58%.
The Momentum Indicator dropped below the 0 level on May 30, 2023. In 47 out of 83 cases where the Momentum Indicator fell below 0, the stock continued to decline within the subsequent month. The odds of a continued downward trend are calculated at 57%.
Following a 3-day decline, it is expected that the stock will experience further falls. Historical data shows that in 50 out of 62 cases where PFE declined for three consecutive days, the price subsequently rose within the following month. The probability of a continued downward trend is estimated at 60%.
PFE broke above its upper Bollinger Band on May 23, 2023. This breakout may indicate an impending drop in the stock's price as it moves back below the upper band towards the middle band. It might be worth considering selling the stock or exploring put options.
The Aroon Indicator for PFE shifted into a downward trend on May 23, 2023. This suggests a potential strong downward movement for the stock. Traders may want to consider selling the stock or purchasing put options.
PFE's Stochastic Oscillator dives oversold zone
The Stochastic Oscillator for PFE moved into oversold territory on June 22, 2026. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PFE advanced for three days, in of 279 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on June 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PFE as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for PFE turned negative on June 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .
PFE moved below its 50-day moving average on June 15, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PFE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for PFE entered a downward trend on May 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.587) is normal, around the industry mean (19.559). P/E Ratio (19.145) is within average values for comparable stocks, (26.481). Projected Growth (PEG Ratio) (13.773) is also within normal values, averaging (15.849). PFE's Dividend Yield (0.069) is considerably higher than the industry average of (0.031). P/S Ratio (2.265) is also within normal values, averaging (3.939).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. PFE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PFE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 66, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of vaccines and injectable biologic medicines
Industry PharmaceuticalsMajor
Advertisement